Click to copy
Click to copy

Seres Therapeutics: 2Q Earnings Snapshot

August 6, 2019

CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Tuesday reported a loss of $10.8 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 24 cents.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

The drug developer posted revenue of $12.5 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $10.3 million.

The company’s shares closed at $2.44. A year ago, they were trading at $7.55.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB

All contents © copyright 2019 The Associated Press. All rights reserved.